Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-20-040413
Filing Date
2020-12-02
Accepted
2020-12-02 13:32:23
Documents
19

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.2 TO FORM F-1 ea130806-f1a2_universepharma.htm F-1/A 2802001
2 CONSENT OF FRIEDMAN LLP ea130806ex23-1_universe.htm EX-23.1 2206
3 REQUEST FOR WAIVERS AND REPRESENTATION UNDER ITEM 8.A.4 OF FORM 20-F ea130806ex99-8_universe.htm EX-99.8 14751
4 GRAPHIC ex23-1_001.jpg GRAPHIC 18513
5 GRAPHIC ex99-8_001.jpg GRAPHIC 47880
6 GRAPHIC fimg_01.jpg GRAPHIC 3877
7 GRAPHIC image_001.jpg GRAPHIC 33493
8 GRAPHIC image_002.jpg GRAPHIC 81053
9 GRAPHIC image_003.jpg GRAPHIC 24136
10 GRAPHIC image_004.jpg GRAPHIC 18618
11 GRAPHIC image_005.jpg GRAPHIC 14301
12 GRAPHIC image_006.jpg GRAPHIC 20017
13 GRAPHIC image_007.jpg GRAPHIC 19549
14 GRAPHIC image_008.jpg GRAPHIC 22074
15 GRAPHIC image_009.jpg GRAPHIC 2001
16 GRAPHIC image_010.jpg GRAPHIC 1876
17 GRAPHIC image_011.jpg GRAPHIC 1477
18 GRAPHIC logo_001.jpg GRAPHIC 57592
19 GRAPHIC logo_002.jpg GRAPHIC 3714
  Complete submission text file 0001213900-20-040413.txt   3331981
Mailing Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100
Business Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100 86-0796-8403309
Universe Pharmaceuticals INC (Filer) CIK: 0001809616 (see all company filings)

EIN.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 0930
Type: F-1/A | Act: 33 | File No.: 333-248067 | Film No.: 201363221
SIC: 2834 Pharmaceutical Preparations